The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Colorectal Cancer Diagnostics & Therapeutics Market Research Report 2025
Synopsis
Colorectal Cancer Diagnostics & Therapeutics refer to the tools, techniques, and treatments aimed at identifying and managing colorectal cancer, a type of cancer that originates in the colon or rectum. Diagnostics include screening methods like colonoscopy, stool tests, and imaging scans to detect the presence of cancerous growths. Therapeutics involve a range of treatments such as surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy, all tailored to the stage and characteristics of the cancer to improve patient outcomes and quality of life.
The global Colorectal Cancer Diagnostics & Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnostics & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnostics & Therapeutics.
Report Scope
The Colorectal Cancer Diagnostics & Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Diagnostics & Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Diagnostics & Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Segment by Type
Colorectal Cancer Diagnostics
Colorectal Cancer Therapeutics
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Diagnostics & Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Colorectal Cancer Diagnostics & Therapeutics refer to the tools, techniques, and treatments aimed at identifying and managing colorectal cancer, a type of cancer that originates in the colon or rectum. Diagnostics include screening methods like colonoscopy, stool tests, and imaging scans to detect the presence of cancerous growths. Therapeutics involve a range of treatments such as surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy, all tailored to the stage and characteristics of the cancer to improve patient outcomes and quality of life.
The global Colorectal Cancer Diagnostics & Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnostics & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnostics & Therapeutics.
Report Scope
The Colorectal Cancer Diagnostics & Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Diagnostics & Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Diagnostics & Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Segment by Type
Colorectal Cancer Diagnostics
Colorectal Cancer Therapeutics
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Diagnostics & Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Colorectal Cancer Diagnostics
1.2.3 Colorectal Cancer Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Perspective (2019-2030)
2.2 Colorectal Cancer Diagnostics & Therapeutics Growth Trends by Region
2.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Colorectal Cancer Diagnostics & Therapeutics Market Dynamics
2.3.1 Colorectal Cancer Diagnostics & Therapeutics Industry Trends
2.3.2 Colorectal Cancer Diagnostics & Therapeutics Market Drivers
2.3.3 Colorectal Cancer Diagnostics & Therapeutics Market Challenges
2.3.4 Colorectal Cancer Diagnostics & Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue
3.1.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Diagnostics & Therapeutics Revenue
3.4 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2023
3.5 Colorectal Cancer Diagnostics & Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2025-2030)
5 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size (2019-2030)
6.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2019-2024)
6.4 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size (2019-2030)
7.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2019-2024)
7.4 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size (2019-2030)
9.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Detail
11.1.2 Biocept Business Overview
11.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Introduction
11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.1.5 Biocept Recent Development
11.2 Cancer Genetics
11.2.1 Cancer Genetics Company Detail
11.2.2 Cancer Genetics Business Overview
11.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.2.5 Cancer Genetics Recent Development
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Detail
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Introduction
11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.3.5 Foundation Medicine Recent Development
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Detail
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.4.5 Sysmex Corporation Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Detail
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.5.5 Danaher Corporation Recent Development
11.6 Epigenomics
11.6.1 Epigenomics Company Detail
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.6.5 Epigenomics Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Introduction
11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Rosetta Genomics
11.8.1 Rosetta Genomics Company Detail
11.8.2 Rosetta Genomics Business Overview
11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.8.5 Rosetta Genomics Recent Development
11.9 Exact Science Corporation
11.9.1 Exact Science Corporation Company Detail
11.9.2 Exact Science Corporation Business Overview
11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.9.5 Exact Science Corporation Recent Development
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Detail
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.10.5 Pathway Genomics Corporation Recent Development
11.11 Taiho Pharma
11.11.1 Taiho Pharma Company Detail
11.11.2 Taiho Pharma Business Overview
11.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Introduction
11.11.4 Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.11.5 Taiho Pharma Recent Development
11.12 Merck KGaA
11.12.1 Merck KGaA Company Detail
11.12.2 Merck KGaA Business Overview
11.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Introduction
11.12.4 Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.12.5 Merck KGaA Recent Development
11.13 Amgen
11.13.1 Amgen Company Detail
11.13.2 Amgen Business Overview
11.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Introduction
11.13.4 Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.13.5 Amgen Recent Development
11.14 Takeda
11.14.1 Takeda Company Detail
11.14.2 Takeda Business Overview
11.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Introduction
11.14.4 Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.14.5 Takeda Recent Development
11.15 Roche
11.15.1 Roche Company Detail
11.15.2 Roche Business Overview
11.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Introduction
11.15.4 Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.15.5 Roche Recent Development
11.16 Eli Lilly
11.16.1 Eli Lilly Company Detail
11.16.2 Eli Lilly Business Overview
11.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Introduction
11.16.4 Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.16.5 Eli Lilly Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Detail
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Introduction
11.17.4 Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.17.5 Sanofi Recent Development
11.18 Regeneron
11.18.1 Regeneron Company Detail
11.18.2 Regeneron Business Overview
11.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Introduction
11.18.4 Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.18.5 Regeneron Recent Development
11.19 Bayer
11.19.1 Bayer Company Detail
11.19.2 Bayer Business Overview
11.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Introduction
11.19.4 Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.19.5 Bayer Recent Development
11.20 Onyx
11.20.1 Onyx Company Detail
11.20.2 Onyx Business Overview
11.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Introduction
11.20.4 Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
11.20.5 Onyx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Colorectal Cancer Diagnostics
Table 3. Key Players of Colorectal Cancer Therapeutics
Table 4. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2019-2024)
Table 8. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2025-2030)
Table 10. Colorectal Cancer Diagnostics & Therapeutics Market Trends
Table 11. Colorectal Cancer Diagnostics & Therapeutics Market Drivers
Table 12. Colorectal Cancer Diagnostics & Therapeutics Market Challenges
Table 13. Colorectal Cancer Diagnostics & Therapeutics Market Restraints
Table 14. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2023)
Table 17. Ranking of Global Top Colorectal Cancer Diagnostics & Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
Table 21. Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Biocept Company Detail
Table 47. Biocept Business Overview
Table 48. Biocept Colorectal Cancer Diagnostics & Therapeutics Product
Table 49. Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Biocept Recent Development
Table 51. Cancer Genetics Company Detail
Table 52. Cancer Genetics Business Overview
Table 53. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product
Table 54. Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Cancer Genetics Recent Development
Table 56. Foundation Medicine Company Detail
Table 57. Foundation Medicine Business Overview
Table 58. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product
Table 59. Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Foundation Medicine Recent Development
Table 61. Sysmex Corporation Company Detail
Table 62. Sysmex Corporation Business Overview
Table 63. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 64. Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Sysmex Corporation Recent Development
Table 66. Danaher Corporation Company Detail
Table 67. Danaher Corporation Business Overview
Table 68. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 69. Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Danaher Corporation Recent Development
Table 71. Epigenomics Company Detail
Table 72. Epigenomics Business Overview
Table 73. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product
Table 74. Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Epigenomics Recent Development
Table 76. Illumina Company Detail
Table 77. Illumina Business Overview
Table 78. Illumina Colorectal Cancer Diagnostics & Therapeutics Product
Table 79. Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Illumina Recent Development
Table 81. Rosetta Genomics Company Detail
Table 82. Rosetta Genomics Business Overview
Table 83. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Product
Table 84. Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 85. Rosetta Genomics Recent Development
Table 86. Exact Science Corporation Company Detail
Table 87. Exact Science Corporation Business Overview
Table 88. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 89. Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 90. Exact Science Corporation Recent Development
Table 91. Pathway Genomics Corporation Company Detail
Table 92. Pathway Genomics Corporation Business Overview
Table 93. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 94. Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 95. Pathway Genomics Corporation Recent Development
Table 96. Taiho Pharma Company Detail
Table 97. Taiho Pharma Business Overview
Table 98. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product
Table 99. Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 100. Taiho Pharma Recent Development
Table 101. Merck KGaA Company Detail
Table 102. Merck KGaA Business Overview
Table 103. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product
Table 104. Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Merck KGaA Recent Development
Table 106. Amgen Company Detail
Table 107. Amgen Business Overview
Table 108. Amgen Colorectal Cancer Diagnostics & Therapeutics Product
Table 109. Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 110. Amgen Recent Development
Table 111. Takeda Company Detail
Table 112. Takeda Business Overview
Table 113. Takeda Colorectal Cancer Diagnostics & Therapeutics Product
Table 114. Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 115. Takeda Recent Development
Table 116. Roche Company Detail
Table 117. Roche Business Overview
Table 118. Roche Colorectal Cancer Diagnostics & Therapeutics Product
Table 119. Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Roche Recent Development
Table 121. Eli Lilly Company Detail
Table 122. Eli Lilly Business Overview
Table 123. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product
Table 124. Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 125. Eli Lilly Recent Development
Table 126. Sanofi Company Detail
Table 127. Sanofi Business Overview
Table 128. Sanofi Colorectal Cancer Diagnostics & Therapeutics Product
Table 129. Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 130. Sanofi Recent Development
Table 131. Regeneron Company Detail
Table 132. Regeneron Business Overview
Table 133. Regeneron Colorectal Cancer Diagnostics & Therapeutics Product
Table 134. Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 135. Regeneron Recent Development
Table 136. Bayer Company Detail
Table 137. Bayer Business Overview
Table 138. Bayer Colorectal Cancer Diagnostics & Therapeutics Product
Table 139. Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 140. Bayer Recent Development
Table 141. Onyx Company Detail
Table 142. Onyx Business Overview
Table 143. Onyx Colorectal Cancer Diagnostics & Therapeutics Product
Table 144. Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024) & (US$ Million)
Table 145. Onyx Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Colorectal Cancer Diagnostics Features
Figure 4. Colorectal Cancer Therapeutics Features
Figure 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Colorectal Cancer Diagnostics & Therapeutics Report Years Considered
Figure 11. Global Colorectal Cancer Diagnostics & Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Colorectal Cancer Diagnostics & Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region: 2023 VS 2030
Figure 14. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Players in 2023
Figure 15. Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2023
Figure 17. North America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2019-2030)
Figure 19. United States Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2019-2030)
Figure 23. Germany Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2019-2030)
Figure 31. China Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2019-2030)
Figure 39. Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2019-2030)
Figure 43. Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Biocept Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 46. Cancer Genetics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 47. Foundation Medicine Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 48. Sysmex Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 49. Danaher Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 50. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 51. Illumina Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 52. Rosetta Genomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 53. Exact Science Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 54. Pathway Genomics Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 55. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 56. Merck KGaA Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 57. Amgen Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 58. Takeda Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 59. Roche Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 60. Eli Lilly Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 61. Sanofi Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 62. Regeneron Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 63. Bayer Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 64. Onyx Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
